Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
Hepatitis C virus (HCV) is an infectious agent that has the potential to cause chronic liver disease, cirrhosis and hepatocellular carcinoma. We determined the prevalence and genotypes of HCV infection among groups of drug addicts: intravenous drug users (n = 134), methamphetamine users (n = 100), inhaled-drugs users (n = 19) and alcoholics (n = 50); a group of blood donors acted as a control. The control group consisted of 179 randomly-selected anti-HCV positive samples: these were subjected to HCV RNA screening and genotyping. The anti-HCV test was performed by ELISA: HCV RNA screening was by nested RT-PCR that employed primers from the 5' noncoding region. The genotype assay was based upon analysis of the 5' NCR amplified sequences and RFLP. Hepatitis C virus was highly prevalent among all groups of drug addicts (12-70%). In 2000. among the new blood donors (n = 66,340) at the National Blood Center, Thai Red Cross, anti-HCV prevalence amounted to 0.98%. The HCV genotype distribution showed that the most prevalent genotype was 3a, followed by 1b and 6a. Our data demonstrated the very high prevalence of HCV infection in IVDUs, a finding that is consistent with the blood-borne nature of the virus. In order to curb HCV infection, a determined effort to educate both the general population and high-risk groups is required; such a program of education would address both general and particular methods of transmission, especially the use of non-sterile needles etc.
Verachai
Viroj
V
Department of Medical Services, Thanyarak Hospital, Pathum Thani, Thailand.
Phutiprawan
Tipwan
T
Theamboonlers
Apiradee
A
Chinchai
Teeraporn
T
Tanprasert
Srivilai
S
Haagmans
Bart L
BL
Osterhaus
Albert D M E
AD
Poovorawan
Yong
Y
D000437:Alcoholism / Q000150:complications*; D019969:Amphetamine-Related Disorders / Q000150:complications*; D001782:Blood Donors / Q000706:statistics & numerical data*; D004797:Enzyme-Linked Immunosorbent Assay; D005838:Genotype; D006266:Health Education; D016174:Hepacivirus / Q000145:classification / Q000235:genetics; D006526:Hepatitis C / Q000453:epidemiology* / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D008403:Mass Screening; D008694:Methamphetamine; D016485:Needle Sharing / Q000706:statistics & numerical data; D020380:Needs Assessment; D011159:Population Surveillance; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D015819:Substance Abuse, Intravenous / Q000150:complications*; D013785:Thailand / Q000453:epidemiology
D012367:RNA, Viral; D008694:Methamphetamine